Lynk Pharmaceuticals
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
291 Fucheng Road Bldg 5-402 Qiantang, Ha...Phone Number
+86 57187711186Website
www.lynkpharma.comRevenue
$8.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Lynk Pharmaceuticals
Lynk Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to discovering and developing novel medicines to treat oncology, immunology and inflammatory diseases. The company is based in Hangzhou, China.Explore more
Popular SearchesLynk Pharmaceuticals Co LtdLynk Pharmaceuticals凌科药业（杭州）有限公司SIC Code 28,283NAICS Code 32,325Show moreLynk Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lynk Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Lynk Pharmaceuticals recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Lynk Pharmaceuticals had a recent Job posting/layoffs
Product Launch: Get notified when Lynk Pharmaceuticals launches new products
Lynk Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Lynk Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Lynk Pharmaceuticals has new funding data
Check out if Lynk Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Lynk Pharmaceuticals
Recommended Actions
Find VP level buyers at Lynk Pharmaceuticals
Find more new buyers
Company Profile Activity
Activity Insights
Lynk Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lynk Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lynk Pharmaceuticals.
Lynk Pharmaceuticals financials insights
Gather financial insights about Lynk Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$20M
2021
Series B
$50M
2023
Series C
$72.2M
Lynk Pharmaceuticals Tech Stack
Most Recent Scoops
Project
Product Development, Legal Affairs, Medical Research, Pharmaceuticals, Regulations
Funding
Funding
Funding
Lynk Pharmaceuticals News & Media
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis
HANGZHOU, China and SHANGHAI and BOSTON, July 14, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that patient enrollment was completed on July 9...Lynk Pharmaceuticals Announces First Patient Dosed in Phase II Clinical Trial of LNK01004 Ointment for Vitiligo
HANGZHOU, China, SHANGHAI and BOSTON, July 8, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on immune and inflammatory diseases, today announced that the first patient was successfully dosed on...Lynk Pharmaceuticals' Partner Formation Bio Doses First Participant in Phase 1 Trial of BLKR201 (originally designated as LNK01006), a CNS-Penetrant TYK2 Inhibitor
HANGZHOU, China, SHANGHAI and BOSTON, June 9, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on autoimmune and inflammatory diseases, today announced a significant clinical milestone achieved by...Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor
Company advances molecule from deal close to Phase 1 five months after in-licensing the asset NEW YORK, June 9, 2026 /PRNewswire/ -- Formation Bio, an AI-native pharma company, today announced dosing of the first participant in a Phase 1, first-in-human (FIH) clinical trial of BLKR201....
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lynk Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Lynk Pharmaceuticals is a clinical-stage pharmaceutical company dedicated to discovering and developing novel medicines to treat oncology, immunology and inflammatory diseases. The company is based in Hangzhou, China.... Read More
